Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?

被引：2
作者：
Brunetti, Natale Daniele [1 ]
De Gennaro, Luisa [2 ]
Di Biase, Matteo [3 ]
Caldarola, Pasquale [2 ]
机构：
[1] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[2] San Paolo Hosp, Cardiol Dept, Bari, Italy
[3] Santa Maria Hosp, GVM Care & Res, Bari, Italy
来源：
IJC HEART & VASCULATURE | 2019年 / 24卷
关键词：
Coronary artery disease; Peripheral artery disease; Rivaroxaban; Ticagrelor; Clinical management; TICAGRELOR; PREVENTION; RATIONALE; ASPIRIN; EVENTS; DESIGN;
D O I：
10.1016/j.ijcha.2019.100401
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PEGASUS study: who would benefit from prolonged DUAL antiplatelet therapy?
    De Luca, Leonardo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2017, 18 : e100 - e104
  • [2] Prolonged dual antiplatelet therapy: Has PEGASUS landed in the real world?
    Gielen, Stephan
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (07) : 693 - 695
  • [3] Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
    Magnani, Giulia
    Denegri, Andrea
    Gurgoglione, Filippo Luca
    Barocelli, Federico
    Indrigo, Elia
    Catellani, Davide
    Signoretta, Gianluca
    Bettella, Alberto
    Tuttolomondo, Domenico
    Solinas, Emilia
    Nicolini, Francesco
    Niccoli, Giampaolo
    Ardissino, Diego
    Surdacki, Andrzej
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (16)
  • [4] Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry
    Cesaro, Arturo
    Gragnano, Felice
    Calabro, Paolo
    Moscarella, Elisabetta
    Santelli, Francesco
    Fimiani, Fabio
    Patti, Giuseppe
    Cavallari, Ilaria
    Antonucci, Emilia
    Cirillo, Plinio
    Pignatelli, Pasquale
    Palareti, Gualtiero
    Pelliccia, Francesco
    Bossone, Eduardo
    Pengo, Vittorio
    Gresele, Paolo
    Marcucci, Rossella
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 7 - 13
  • [5] Role of Antiplatelet and Anticoagulant Therapy in Management of Peripheral Artery Disease
    Park, Byung Joon
    Hou, Linle
    Galmer, Andrew
    Johnston-Cox, Hillary
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2023, 25 (09) : 379 - 390
  • [6] Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease Focus on the COMPASS Trial
    Gurbel, Paul A.
    Fox, Keith A. A.
    Tantry, Udaya S.
    ten Cate, Hugo
    Weitz, Jeffrey, I
    CIRCULATION, 2019, 139 (18) : 2170 - 2185
  • [7] Antiplatelet and anticoagulant therapy in carotid endarterectomies
    Orlicky, M.
    Vachata, P.
    Waldauf, P.
    Sames, M.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2018, 81 (04) : 444 - 449
  • [8] Indications for anticoagulant and antiplatelet combined therapy
    Floyd, Christopher N.
    Ferro, Albert
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 359
  • [9] Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience
    Effron, Mark B.
    Gibson, C. Michael
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 531 - 536
  • [10] Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery
    Ryan, Andrea
    Saad, Tahira
    Kirwan, Caitriona
    Keegan, David J.
    Acheson, Robert W.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (04) : 387 - 395
12345